Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells
- 1 December 1993
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 23 (12) , 3120-3125
- https://doi.org/10.1002/eji.1830231212
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- In situ expression of B7/BB1 on antigenpresenting cells and activated B cells: an immunohistochemical studyInternational Immunology, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Functional characterization of a novel anti‐B7 monoclonal antibodyEuropean Journal of Immunology, 1992
- T helper cellsCurrent Opinion in Immunology, 1992
- Interleukin (IL)‐4 production by human T cells: differential regulation of IL‐4 vs. IL‐2 productionEuropean Journal of Immunology, 1992
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992
- Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.The Journal of Experimental Medicine, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- A new superfamily of cell surface proteins related to the nerve growth factor receptorImmunology Today, 1991
- The molecules controlling B lymphocytesImmunology Today, 1987